original ) (raw )Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules
Seyed Jalal Hosseinimehr
Amino Acids, 2012
View PDFchevron_right
Development and preclinical characterisation of 99m Tc-labelled Affibody molecules with reduced renal uptake
Thuy Tran
European Journal of Nuclear Medicine and Molecular Imaging, 2008
View PDFchevron_right
Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
Seyed Jalal Hosseinimehr
Journal of Nuclear Medicine, 2011
View PDFchevron_right
Positioning of 99mTc-chelators influences radiolabeling, stability and biodistribution of Affibody molecules
Joachim Feldwisch
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99m Tc to Tumor-Targeting Affibody Molecules
Anna Orlova , Vladimir Tolmachev
Bioconjugate Chemistry, 2007
View PDFchevron_right
HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [ 99m Tc(CO) 3 ] + -Labeled Affibody Molecules
Seyed Jalal Hosseinimehr
Journal of Medicinal Chemistry, 2013
View PDFchevron_right
In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99m Tc to Tumor-Targeting Affibody Molecules
Alexander Bruskin
Bioconjugate Chemistry, 2007
View PDFchevron_right
Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules
Vladimir Tolmachev
European Journal of Nuclear Medicine and Molecular Imaging, 2009
View PDFchevron_right
Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re
Anna Orlova , Z. Varasteh , Vladimir Tolmachev
European journal of medicinal chemistry, 2014
View PDFchevron_right
99m Tc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule
lars abrahmsen
European Journal of Nuclear Medicine and Molecular Imaging, 2007
View PDFchevron_right
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent
Darryl McDougald
Nuclear Medicine and Biology, 2020
View PDFchevron_right
Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules
Mattias Sandström
Bioconjugate Chemistry, 2008
View PDFchevron_right
New small 99mTc-labeled peptides for HER2 receptor imaging
hamideh sabahnoo
European Journal of Medicinal Chemistry, 2017
View PDFchevron_right
Comparative Preclinical Evaluation of Peptide-Based Chelators for Labeling of DARPin G3 with 99mTc for Radionuclide Imaging of HER2 Expression in Cancer
Evgenii Plotnikov
View PDFchevron_right
Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine
Vladimir Tolmachev
Nuclear medicine and biology, 2010
View PDFchevron_right
Targeting of HER2Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
lars abrahmsen
Journal of Nuclear Medicine, 2009
View PDFchevron_right
Preclinical Evaluation of 99mTc-ZHER2:41071, a Second-Generation Affibody-Based HER2-Visualizing Imaging Probe with a Low Renal Uptake
Joachim Feldwisch
International Journal of Molecular Sciences
View PDFchevron_right
Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein
Hans Lundqvist
Journal of Nuclear Medicine, 2013
View PDFchevron_right
Reduction of renal activity retention of radiolabeled albumin binding domain‑derived affinity proteins using a non‑residualizing label strategy compared with a cleavable glycine‑leucine‑glycine‑lysine‑linker
maryam oroujeni
Molecular Medicine Reports, 2023
View PDFchevron_right
99mTc-HYNIC-derivatized ternary ligand complexes for 99mTc-labeled polypeptides with low in vivo protein binding
Kazuma Ogawa
Nuclear Medicine and Biology, 2001
View PDFchevron_right
Plasma protein binding of 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides
Kazuma Ogawa
Nuclear Medicine and Biology, 2001
View PDFchevron_right
Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m
Javad Garousi
Scientific reports, 2017
View PDFchevron_right
Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence
Anna Orlova , Vladimir Tolmachev
European Journal of Nuclear Medicine and Molecular Imaging, 2007
View PDFchevron_right